Insecticides (India) Limited (INSECTICID) AI Stock Analysis

• Market Cap: ₹22.16B
• Dividend Yield: 0.66%
• Average Volume (3M): 2.65K
• Price to Earnings (P/E): 14.8
• Beta (1Y): 1.05
• Revenue Growth: 2.61%
• EPS Growth: 24.65%
• Country: IN
• Employees: 1,615
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Agricultural Inputs
• EPS (TTM): 19.97
• Shares Outstanding: 29,097,837
• 10 Day Avg. Volume: 1,754
• 30 Day Avg. Volume: 2,649
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,005.00
• Price Target Upside: 31.99% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 72 Outperform
• Price Target: ₹1,005.00 ▲(31.99% Upside)

Insecticides (India) Limited shows strong financial performance with robust revenue and profit growth, contributing significantly to the overall score. Technical analysis indicates a bearish trend but potential for reversal, while valuation metrics suggest the stock is fairly valued. The absence of earnings call and corporate events data limits additional insights.

Insecticides (India) Limited Business Overview & Revenue Model

Company Description

Insecticides (India) Limited manufactures and sells agro chemicals, pesticides, and technical products for agriculture purposes in India and internationally. The company offers insecticides, herbicides, fungicides, and PGRs and bio fertilizers. It also provides household and biological products, and formulations. The company sells its products through a network of approximately 5000 distributors and 60000 retailers under the Tractor brand name. Insecticides (India) Limited was incorporated in 1996 and is based in Delhi, India.

How the Company Makes Money

Insecticides (India) Limited generates revenue primarily through the sale of its agrochemical products, which cater to the needs of farmers and agricultural businesses. The company's key revenue streams include the manufacturing and distribution of insecticides, herbicides, and fungicides. These products are sold through an extensive network of distributors and retailers across India. In addition to domestic sales, the company may also engage in export activities, contributing to its revenue. Strategic partnerships with research institutions and technology providers help in the development of new products and solutions, thereby enhancing the company's competitive edge in the market. Furthermore, Insecticides (India) Limited invests in marketing and promotional activities to increase brand awareness and expand its customer base, which also plays a crucial role in driving sales and revenue.

Insecticides (India) Limited Financial Statement Overview

Summary

Insecticides (India) Limited demonstrates a positive financial trajectory with strong revenue and profit growth, a stable balance sheet, and healthy cash flow generation. While there are some operational and financial risks, such as fluctuating EBIT margins and rising liabilities, the company's financial health remains robust in the Agricultural Inputs industry.

Income Statement

Insecticides (India) Limited has shown consistent revenue growth with a substantial increase from 14,021 million in 2021 to 19,999 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management. The net profit margin has also strengthened, reflecting enhanced profitability. However, the EBIT margin has fluctuated, which suggests some operational challenges.

Balance Sheet

The company maintains a solid equity base with an increasing trend in stockholders' equity from 8,203 million in 2021 to 10,846 million in 2025. The debt-to-equity ratio is relatively low and manageable, indicating prudent leverage. The equity ratio shows a stable asset financing structure. Nonetheless, the consistent rise in total liabilities could pose future financial risks.

Cash Flow

Insecticides (India) Limited exhibits a strong free cash flow position with growth over the years, except for a dip in 2023. The operating cash flow to net income ratio indicates robust cash generation relative to reported profits. However, fluctuations in free cash flow highlight potential volatility in capital expenditure and financing activities.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	19.14B	20.00B	19.56B	17.97B	14.98B	14.12B
Gross Profit	5.62B	6.41B	4.80B	3.99B	3.79B	3.35B
EBITDA	2.06B	2.29B	1.72B	1.21B	1.73B	1.48B
Net Income	1.36B	1.42B	1.02B	632.11M	1.07B	939.03M
Balance Sheet
Total Assets	0.00	18.98B	17.13B	16.96B	13.96B	14.26B
Cash, Cash Equivalents and Short-Term Investments	715.72M	666.26M	613.50M	196.42M	360.96M	81.44M
Total Debt	0.00	1.05B	873.09M	1.63B	539.50M	1.00B
Total Liabilities	-11.18B	8.14B	7.00B	7.78B	5.27B	6.06B
Stockholders Equity	11.18B	10.85B	10.14B	9.18B	8.70B	8.20B
Cash Flow
Free Cash Flow	0.00	561.68M	1.35B	-980.91M	675.70M	1.07B
Operating Cash Flow	0.00	934.57M	1.84B	-106.33M	1.35B	1.55B
Investing Cash Flow	0.00	-377.20M	-429.91M	-864.03M	93.09M	-1.13B
Financing Cash Flow	0.00	-610.92M	-980.58M	796.80M	-1.15B	-1.04B

Insecticides (India) Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 761.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INSECTICID, the sentiment is Negative. The current price of 761.4 is below the 20-day moving average (MA) of 787.22, below the 50-day MA of 888.20, and above the 200-day MA of 758.73, indicating a neutral trend. The MACD of -30.65 indicates Negative momentum. The RSI at 34.07 is Neutral, neither overbought nor oversold. The STOCH value of 31.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INSECTICID.

Insecticides (India) Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INSECTICID	72 Outperform	₹22.16B	14.79	―	0.66%	2.61%	24.65%
DALMIASUG	72 Outperform	₹28.07B	7.58	11.96%	1.73%	23.22%	39.31%
RANASUG	65 Neutral	₹2.18B	5.94	5.98%	―	14.60%	152.99%
ANDHRSUGAR	62 Neutral	₹10.04B	29.04	1.63%	1.08%	13.67%	-49.78%
BAJAJHIND	47 Neutral	₹25.57B	-18.25	-0.56%	―	-11.30%	-73.75%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Insecticides (India) Limited Corporate Events

Insecticides (India) Limited Announces Q1 FY26 Earnings Conference Call

Insecticides (India) Limited has scheduled an earnings conference call on August 13, 2025, to discuss its Q1 and FY26 financial results. The call will feature key company executives, including the Managing Director, CFO, and Chief Marketing Officer, and will provide insights into the company’s financial performance and strategic direction.